Jump to:Page Content
Stand out from the crowd! Advertise in Trial to reach a national audience of major decision-makers who are looking for products and services to improve their legal practices.
Alyssa E. Lambert
The Supreme Court recently held 5-4 that design defect claims that turn on the adequacy of a generic drug’s warnings are preempted under Mensing, allowing generic drug companies to escape liability. But the FDA is planning to publish a new drug labeling rule in September.